S

Southwest Retina Specialists | Amarillo, TX

Research site

(Unclaimed)

Location

7411 Wallace Boulevard, Amarillo, Texas, United States of America

Site insights

Top conditions

Top treatments

Ranibizumab

KSI-301

Bevacizumab

Zimura

Aflibercept

ranibizumab

EYE103

ANX007

EYE201

Avacincaptad pegol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 13 total trials

Locations recently updated

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) (MALBEC)

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD).Available standard (usual) treatments for NVAMD, s...

Enrolling

Choroidal Neovascularization

Age-Related Macular Degeneration

Drug: Tiespectus

Drug: Aflibercept

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) (ARCHER II)

The primary purpose of the study is to determine if IVT injections of vonaprument every month reduce vision loss in participants with dry AMD with GA.

Active, not recruiting

Geographic Atrophy

Drug: Vonaprument

Other: Sham Administration

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME (BRUNELLO)

EYE-RES-102 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active...

Active, not recruiting

Diabetic Macular Edema (DME)

Drug: EYE103

Drug: Ranibizumab